Treatment of Anxiety Disorders in a Psychology Clinic

  1. Labrador Encinas, Francisco Javier
  2. Estupiñá Puig, Francisco José
  3. Bernaldo de Quirós, Mónica
  4. Fernández Arias, Ignacio
  5. Alonso, Pablo
  6. Ballesteros Pérez, Francisco
  7. Blanco, Carmen
  8. Gómez Mirón, Laura
Revista:
The Spanish Journal of Psychology

ISSN: 1138-7416

Año de publicación: 2015

Volumen: 18

Tipo: Artículo

DOI: 10.1017/SJP.2015.82 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: The Spanish Journal of Psychology

Resumen

People with anxiety disorders demand psychological attention most often. Therefore, it seems important to identify both the characteristics of the patients who demand help and the clinical variables related to that demand and its treatment. A cohort of 292 patients who requested help at a university clinical facility was studied. The typical profile of the patient was: being female, young, unmarried, with some college education, and having previously received treatment, especially pharmacological one. The three most frequent diagnoses of anxiety, which include 50% of the cases, were: Anxiety Disorder not otherwise specified, Social Phobia, and Panic Disorder with Agoraphobia. Regarding the characteristics of the intervention, the average duration of the assessment was 3.5 sessions (SD = 1.2), and the duration of the treatment was 14 sessions (SD = 11.2). The percentage of discharges was 70.2%. The average cost of treatment was around �840. The results are discussed, underlining the value of empirically supported treatments for anxiety disorders.

Referencias bibliográficas

  • American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th Ed.). Washington, DC: Author.
  • American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (4th Ed., Rev.). Washington, DC: Author.
  • Arenas M. C., & Puigcever A. (2009). Diferencias entre hombres y mujeres en los trastornos de ansiedad: Una aproximación psicobiológica [Differences between men and women in the anxiety disorders: A psychobiological approach]. Escritos de Psicología, 3, 20–29.
  • Bados A., Balaguer G., & Saldaña C. (2007). Outcome of cognitive–behavioral therapy in training practice with anxiety disorder patients. British Journal of Clinical Psychology, 46, 429–435. http://dx.doi.org/10.1348%2F014 466507X209961
  • Bayer J. K., Hiscock H., Ukoumunne O. C., Price A., & Wake M. (2008). Early childhood aetiology of mental health problems: A longitudinal population-based study. Journal of Child Psychology and Psychiatry, 49, 1166–1174. http://dx.doi.org/10.1111%2Fj.1469-7610.2008.01943.x
  • Beck A. T., & Steer R. A. (1993). Beck Anxiety Inventory manual. San Antonio, TX: Harcourt Brace and Company.
  • Beck A. T., Steer R. A., & Brown G. K (1996). Manual for the Beck Depression Inventory – II. San Antonio, TX: Psychological Corporation
  • Bienvenu O. J., Davydow D. S., & Kendler K. S. (2011). Psychiatric ‘diseases’ versus behavioral disorders and degree of genetic influence. Psychological Medicine, 41, 33–40. http://dx.doi.org/10.1017%2FS003329171000084X
  • Bijl R., Ravelli A., & van Zessen G. (1998). Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Social Psychiatry and Psychiatric Epidemiology, 33, 587–595. http://dx.doi.org/10.1007%2Fs001270050098
  • Caballero L., Fernández-Liria A., Ramos J. A., Gil A., Madrigal M., Porras A., … Agüera L. F. (1999). Prevalencia de los trastornos psiquiátricos en atención primaria usando el cuestionario PRIME-MD® [Prevalence of psychiatric disorders in primary healthcare through the PRIME-MD® questionnaire]. Atención Primaria, 23, 275–279.
  • Canino G. J., Bird H. R., Shrout P. E., Rubio-Stipec M., Bravo M., Martinez R., … Guevara L. M. (1987). The prevalence of specific psychiatric disorders in Puerto Rico. Archives of General Psychiatry, 44, 727–735. http://dx.doi.org/10.1001%2Farchpsyc.1987.01800200053008
  • Cano-Vindel A., & Miguel-Tobal J. J. (1999). Evaluación de la ansiedad desde un enfoque interactivo y multidimensional: El Inventario de Situaciones y Respuestas de Ansiedad (ISRA) [Evaluation of the anxiety from an interactive and multidimensional approach: The Inventory of Anxiety Situations and Answers (ISRA)]. Psicología Contemporánea, 6, 14–21.
  • Chambless D. L., Caputo G. C., Bright P., & Gallagher R. (1984). Assessment of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. Journal of Consulting and Clinical Psychology, 52, 1090–1097. http://dx.doi.org/10.1037//0022-006X.52.6.1090
  • Chambless D. L., Caputo G. C., Jasin S. E., Gracely E. J., & Williams C. (1985). The Mobility Inventory for Agoraphobia. Behaviour Research and Therapy, 23, 35–44. http://dx.doi.org/10.1016/0005-7967(85)90140-8
  • Chambless D. L., & Ollendick T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685–716. http://dx.doi.org/10.1146%2Fannurev.psych.52.1.685
  • Demertzis K. H., & Craske M. G. (2006). Anxiety in primary care. Current Psychiatry Reports, 8, 291–297. http://dx.doi.org/10.1007%2Fs11920-006-0065-4
  • Demyttenaere K., Bonnewyn A., Bruffaerts R., De Girolamo G., Gasquet I. , Kovess., … Alonso J. (2008). Clinical factors influencing the prescription of antidepressants and benzodiazepines: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). Journal of Affective Disorder, 110, 84–93. http://dx.doi.org/10.1016%2Fj.jad.2008.01.011
  • Derogatis L. R. (1994). SCL-90-R, Brief Symptom Inventory, and matching clinical rating scales. In M. Maruish (Ed.), Psychological Testing, Treatment Planning, and Outcome Assessment. New York, NY: Erlbaum.
  • Derogatis L. R. (2001). Cuestionario de 90 síntomas (SCL-90-R) [Questionnaire of 90 symptoms (SCL-90-R)]. Madrid, Spain: TEA Ediciones, S.A.
  • Durham R. C., Chambers J. A., MacDonald R. R., Power K. G., & Major K. (2003). Does cognitive-behavioral therapy influence the long-term outcome of generalized anxiety disorder? An 8–14 year follow-up of two clinical trials. Psychological Medicine, 33, 499–509. http://dx.doi.org/10.1017%2FS0033291702007079
  • Gaston J. E., Abbott M. J., Rapee R. M., & Neary S. A. (2006). Do empirically supported treatments generalize to private practice? A benchmark study of a cognitive behavioral group treatment program for social phobia. British Journal of Clinical Psychology, 45, 33–48. http://dx.doi.org/10.1348%2F014466505X35146
  • Gould R. A., Buckminster S., Pollack M. H., Otto M. W., & Yap L. (1997). Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. Clinical Psychology: Science and Practice, 4, 291–306. http://dx.doi.org/10.1111%2Fj.1468-2850.1997.tb00123.x
  • Hahlweg K., Fiegenbaum W., Frank M., Schroeder B., & von Witzleben I. (2001). Shortand long-term effectiveness of an empirically supported treatment for agoraphobia. Journal of Consulting and Clinical Psychology, 69, 375–382. http://dx.doi.org/10.1037%2F0022-006X.69.3.375
  • Herrero M., González E., Valverde T., & Caballero L. (2001). Utilización del cuestionario PRIME-MD® para la detección de trastornos mentales en mujeres inmigrantes iberoamericanas e hispanohablantes [Use of Questionnaire PRIME-MD® for the detection of mental disorders in Spanish-speaking Latin American’s immigrants women]. Medicina Clínica, 117, 716–717. http://dx.doi.org/10.1016%2FS0025-7753%2801%2972232-4
  • Haro J. M., Palacín C., Vilagut G., Martínez M., Bernal M., Luque I., … Grupo ESEMeD-España (2006). Prevalencia de los trastornos mentales y factores asociados: Resultados del estudio ESEMeD-España [Prevalence of mental disorders and associate factors: Results of the ESEMeDSpain study]. Medicina Clínica, 126, 445–451. http://dx.doi.org/10.1157%2F13086324
  • Hunsley L., & Mash E. J. (2008). A guide to assessments that work. New York, NY: Oxford University Press.
  • Kendall P. C., Hudson J. L., Gosch E., Flannery-Schroeder E., & Suveg C. (2008). Cognitive-behavioral therapy for anxiety disordered youth: A randomized clinical trial evaluating child and family modalities. Journal of Consulting and Clinical Psychology, 76, 282–297. http://dx.doi.org/10.1037%2F0022-006X.76.2.282
  • Kessler R. C., Chiu W. T., Demler O., & Walters E. E. (2005). Prevalence, severity and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627. http://dx.doi.org/10.1001%2Farchpsyc.62.6.617
  • Kroenke K., Spitzer R. L., Williams J., Monahan P. O., & Lowe B. (2007). Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Annals of Internal Medicine, 146, 317–325. http://dx.doi.org/10.7326%2F0003-4819-146-5-200703060-00004
  • Labrador F. J., & Ballesteros F. (2011). Efectividad de los tratamientos para la fobia social en el ámbito aplicado [Effectiveness of the treatments for the social phobia in an applied field]. Psicothema, 23, 560–565.
  • Labrador F. J., Estupiñá F. J., & García-Vera M. P. (2010). Demanda de atención psicológica en la práctica clínica [Psychological care demand in clinical practice: Treatment and results]. Psicothema, 22, 619–626.
  • Lincoln T. M., Rief W., Hahlweg K, Frank M, von Witzleben I., Schroeder B., & Fiegenbaum W. (2003). Effectiveness of an empirically supported treatment for social phobia in the field. Behaviour Research and Therapy, 41, 1251–1269. http://dx.doi.org/10.1016%2FS0005-7967%2803%2900038-X
  • Meyer T. J., Miller M. L., Metzger R. L., & Borkovec T. D. (1990). Development and validation of the Penn State Worry Questionnaire. Behaviour Research and Therapy, 28, 487–495. http://dx.doi.org/10.1016/0005-7967(90)90135-6
  • Millon T. (1987). Millon Clinical Multiaxial Inventory-II manual. Minneapolis. MN: National Computer Systems.
  • Millon T. (1998). MCMI-II. Inventario Clínico Multiaxial de Millon II. Manual [Millon Clinical Multiaxial Inventory II. Manual]. Madrid, Spain: TEA.
  • Ministerio de Sanidad y Consumo. (2006). Encuesta Nacional de Salud en España 2006 [National survey of Health in Spain 2006]. Madrid, Spain: Author.
  • Ministerio de Sanidad y Consumo (2007). Estrategia en salud mental del Sistema Nacional de Salud, 2006 [Strategy in mental health of the National Health System, 2006]. Madrid, Spain: Author.
  • Mitte K. (2005) A meta-analysis of the efficacy of psychoand pharmacotherapy in panic disorder with and without agoraphobia. Journal of Affective Disorders 88, 27–45. http://dx.doi.org/10.1016%2Fj.jad.2005.05.003
  • Muñoz M. (2008) Proceso de evaluación psicológica cognitivo – conductual: Una guía de actuación [Process of cognitive-behavioral psychological assessment: A performance guide]. In Labrador, F. J. (Coord.), Técnicas de modificación de conducta [Techniques of behavior modification] (69–101). Madrid, Spain: Pirámide.
  • Otto M. W., Pollack M. H., & Maki K. M. (2000). Empirically supported treatments for panic disorder: Costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology, 68, 556–563. http://dx.doi.org/10.1037%2F%2F0022-006X.68.4.556
  • Otto M. W., Smits J. A. J., & Reese H. E. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice, 12, 72–86. http://dx.doi.org/10.1093%2Fclipsy.bpi009
  • Rachman S., & Hodgson R. J. (1980) Obsessions and compulsions. Englewood Cliffs, NJ: Prentice Hall.
  • Regier D. A., Rae D. S., Narrow W. E., Kaelber C. T., & Schatzberg A. F. (1998). Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. British Journal of Psychiatry, 173, 24–28.
  • Rettew D. C., Lynch A. D., Achenbach T. M., Dumenci L., & Ivanova M. Y. (2009). Meta-analyses of agreement between diagnoses made from clinical evaluations and standardized diagnostic interviews. International Journal of Methods in Psychiatric Research, 18, 169–184. http://dx.doi.org/10.1002%2Fmpr.289
  • Sánchez Meca J., Rosa A. I., & Olivares J. (2004). El tratamiento de la fobia social específica y generalizada en Europa: Un estudio meta-analítico [The treatment of the specific and generalized social phobia in Europe: An metanalytical study ]. Anales de Psicología, 20, 55–68.
  • Somers J. M., Goldner E. M., Waraich P., & Hsu L. (2006). Prevalence and incidence studies of anxiety disorders: Review of the literature. Canadian Journal of Psychiatry, 51, 100–113.
  • Spielberger C. D., Gorsuch R., & Lushene R. (1970). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist.
  • Spielberger C. D., Gorsuch R. L. & Lushene R. E. (2008). STAI. Cuestionario de ansiedad estado-rasgo. [STAI. State-trait anxiety inventory] (7th Ed. Rev.). Madrid, Spain: TEA.
  • Valero M., & Ruiz M. A. (2003). Evaluación de un servicio de Salud Mental: Análisis de la demanda y datos epidemiológicos [Evaluation of a Mental Health service: Analysis of the demand and epidemiological data ]. Psiquis, 2, 11–18.
  • Vallejo M. A., Jordán C. M., Díaz M. I., Comeche M. I., Ortega J., Amor P., & Zubeidat I. (2008). Perfil sociodemográfico de los usuarios de un servicio de asistencia psicológica online [Sociodemographic profile of the users of a service of psychological attendance online]. Psicothema, 20, 610–615.
  • Van Ingen D. J., Freiheit S. R., & Vye C. S. (2009). From the lab to the clinic: Effectiveness of cognitive–behavioral treatments for anxiety disorders. Professional Psychology: Research and Practice, 40, 69–74. http://dx.doi.org/10.1037%2Fa0013318
  • Wagner R., Silove D., Joukhador J., Manicavasagar V., Marnane C., & Kirsten L. T. (2005). Characteristics of the first 1000 clients attending an anxiety clinic in South West Sydney. Australian Journal of Psychology, 57, 180–185. http://dx.doi.org/10.1080%2F00049530500125207
  • Watson D., & Friend R. (1969). Measurement of socialevaluative anxiety. Journal of Consulting and Clinical Psychology, 33, 448–457. http://dx.doi.org/10.1037/h0027806
  • Yonkers K. A., Bruce S. E., Dyck R. H., & Keller M. B. (2003). Chronicity, relapse, and illness course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow-up. Depression and Anxiety, 17, 173–179. http://dx.doi.org/10.1002%2Fda.10106